{"title":"Therapeutic potential of bone marrow-derived endothelial progenitor cells for cardiovascular ischemic diseases","authors":"T. Asahara, A. Kawamoto, C. Kalka, H. Masuda","doi":"10.1163/156855801760107028","DOIUrl":null,"url":null,"abstract":"Post-natal vasculogenesis has been considered to be involved in neovascularization of adult tissues, after bone marrow-derived endothelial progenitor cells (EPCs) were isolated from circulating mononuclear cells in peripheral blood and shown to incorporate into sites of physiological and pathological neovascularization and differentiate into mature endothelial cells (ECs). Following these findings, the various strategies to enhance neovascularization using EPCs have been researched, such as in vivo mobilization through exogenous administration of angiogenic factors, ex vivo culture expansion for cell transplantation or gene therapy. EPCs might have an attractive potential in therapeutic application for cardiovascular ischemic diseases as a novel cell strategy.","PeriodicalId":93646,"journal":{"name":"Gene therapy and regulation","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2001-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1163/156855801760107028","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gene therapy and regulation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1163/156855801760107028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Post-natal vasculogenesis has been considered to be involved in neovascularization of adult tissues, after bone marrow-derived endothelial progenitor cells (EPCs) were isolated from circulating mononuclear cells in peripheral blood and shown to incorporate into sites of physiological and pathological neovascularization and differentiate into mature endothelial cells (ECs). Following these findings, the various strategies to enhance neovascularization using EPCs have been researched, such as in vivo mobilization through exogenous administration of angiogenic factors, ex vivo culture expansion for cell transplantation or gene therapy. EPCs might have an attractive potential in therapeutic application for cardiovascular ischemic diseases as a novel cell strategy.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
